•Maybe you found yourself in the hospital’s ER because you thought you were having a heart attack only to be told later it was anxiety?
•Do you ever fear you might stop breathing because your chest feels tight and your breathing erratic?
•When you drive do you fear the idea of getting stuck in traffic, on a bridge or at red lights?
•Do you ever feel nervous and afraid you might lose control or go insane?
•Have you struggled with anxious thoughts that will not stop?
•Do you ever feel uncomfortable in enclosed spaces such as supermarkets, cinemas, public transport or even sitting at the hair dressers?
•Are you nervous and on edge in normal situations that never bothered you before?
Check www.reliefofanxiety.com
In early March, the artist and TED Prize winner JR announced his wish to turn the world “Inside Out.” Through his InsideOut Project, JR invited people around the globe to share a photo portrait – along with a statement about what they stand for – and paste the pictures in their communities. A group of photographers and organizers in Tunisia were the first to participate in an InsideOut community project, which they named Artocracy.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/ted/49671/
When the first Beetle rolled off the production line, it was called simply the Volkswagen — “the people’s car” — but its distinctive shape inspired nicknames across the globe: Beetle, Käfer, Vocho, Coccinelle, Fusca, Maggiolino or ! In total, 21.5 million cars were sold.
More than 60 years later, in 1998, the “New Beetle” rekindled the spirit and imagination of the original to a new generation of Volkswagen owners. The second generation version sparked another round of uplifting and joyous enthusiasm known as Beetle Mania.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/vw/40222/
From a four-ton elephant to tiny fly larvae, American Humane Association was on the set of “Water for Elephants” ensuring that every animal in the production was treated humanely and kept safe. American Humane Association awarded this 20th Century Fox film its highest rating, “Monitored: Outstanding - ‘No Animals Were Harmed’ ®.”
“It’s a big endorsement to get from the American Humane Association,” said lead actress Reese Witherspoon. “They’re very conscious of how the animals are treated. They’re on set every day, making sure the animals were provided safe facilities and safe transportation and that they can only work a certain amount of hours. They are just the happiest animals — you can tell!”
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/americanhumane/49834/
When Habitat for Humanity St. Louis (HFHSL) identified vacant property just north of downtown, the construction team wanted to build homes that were not only energy efficient but safe for its new tenants.
And with Model Building Codes now requiring new single- and two-family dwellings to be outfitted with sprinkler systems, Habitat chose to go with copper systems for all of its new homes, including the six that were completed this spring.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/copperdevelopmentassociation/50133/
Following their dramatic victory in the 137th Kentucky Derby on Saturday, the connections of Animal Kingdom were presented with The Longines Column-Wheel Chronograph, the official watch of the Kentucky Derby at the event’s exclusive Winners’ Circle Gala.
Owner Barry Irwin, trainer Graham Motion and jockey Johnny Velazquez received the watches from Jennifer Judkins, U.S. Brand President for Longines, the Official Watch and Timekeeper of the Kentucky Derby and Churchill Downs.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/longines/49667/
EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced today that new 10 year data from an international registry-based multi-center study shows 83 percent of patients had no biopsy evidence of disease after treatment with Ablatherm® HIFU, supporting the technology as a standard primary treatment for localized prostate cancer. Study results were presented at the American Urological Association (AUA) 2011 Annual Meeting, Washington, D.C.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/edap/49862/
Landmark public health campaign DRIVE4COPD announced today that Tim Wright was chosen from more than 150 entries as the winner of the Tune Up for COPD Songwriting Competition. DRIVE4COPD Celebrity Ambassadors Billy Ray Cyrus and Patty Loveless were among the judges for the competition, launched in partnership with the Country Music Association (CMA), which challenged Americans to create a new DRIVE4COPD song to help raise awareness of chronic obstructive pulmonary disease (COPD).
To view Multimedia News Release, go to http://www.multivu.com/players/English/48274-boehringer-ingelheim-tuneupforcopd/
Carson-Dellosa Publishing, LLC, in partnership with Guinness World Records, announced the grand-prize winner in its Guinness World Records® Classroom Challenge at a record-breaking event held Friday, May 20th in Owingsville, KY. As grand-prize winners under the direction of 4th Grade teacher Jessica Goldy, the students of Owingsville Elementary School created the world’s longest friendship bracelet. Students created a total of 3,799 links that were connected to make one bracelet measuring 810 feet. Friday morning, under the supervision of a Guinness World Records® adjudicator, the exciting event was held on the school’s football field.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/carsondellosa/50387/
Today, Target Corp.® (NYSE:TGT) announced 42 new schools from across the country that will receive a new library as part of the 2011 Target School Library Makeover program. Education experts and advocates such as Alma Powell of the America’s Promise Alliance and Sir Ken Robinson, along with elected officials including Congressman John Kline, Chairman of the Education and the Workforce Committee and Congressman Gene Green (TX-29), were invited to celebrate this announcement with the principals at the Library of Congress. Additionally, principals from among the 42 elementary schools participated in a Principal Summit, led by Ralph Smith of The Annie E. Casey Foundation. The summit was designed to inspire school leaders, provide best practices for cultivating reading skills by using their new libraries, and explore how educators approach literacy strategies.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/target/50372/
Six of 13 small cars recently evaluated by the Insurance Institute for Highway Safety earn the TOP SAFETY PICK award, and none earn a poor rating in any of 4 tests. This is a turnaround from a few years ago when small cars struggled to earn top safety ratings. The new tests include hybrids and gasoline-only models that are among the most fuel-efficient vehicles available in the U.S. market.
The ratings are based on performance in front, side, rollover, and rear impact evaluations. Cars that earn the top rating of good in each test and have available electronic stability control (ESC) qualify for TOP SAFETY PICK. Winners are the 2012 Ford Focus and Honda Civic, along with the 2011 Hyundai Elantra, Lexus CT 200h hybrid, Nissan Juke, and Toyota Prius hybrid. The Civic, CT 200h, Elantra, Focus, and Prius have at least one version with a government fuel economy rating of at least 40 miles per gallon on the highway. The Dodge Caliber, Honda CR-Z and Insight hybrids, Nissan Sentra and Versa, Scion xD, and Suzuki SX4 also were rated but didn’t earn TOP SAFETY PICK.
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/